New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 15, 2012
09:58 EDTSPEXSpherix, Fullife Healthcare sign supply and license agreement
Spherix Incorporated and Fullife Healthcare announced the signing of a supply and license agreement for the use of D-tagatose in nutraceutical products in India. Under the terms of the agreement, Spherix has granted Fullife an exclusive, royalty-bearing license in India for use of Spherix's clinical data and proprietary know-how to support marketing and dosing of the D-tagatose that Spherix will also be supplying. The D-tagatose will be used in food or cosmetic products that may provide health benefits in return for a fixed royalty on gross sales. Spherix will provide bulk D-Tagatose to Fullife and Fullife will be responsible for all testing and development of products containing D-Tagatose for sale in India. Financial terms of the agreement were not disclosed.
News For SPEX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 1, 2014
06:06 EDTSPEXSpherix announces Markman hearing date for VTech, UNIDEN litigation
Subscribe for More Information
September 22, 2014
06:05 EDTSPEXSpherix issued new U.S. patent
Spherix announced that the United States Patent & Trademark Office issued a new patent to the company in the month of September that is part of a standard essential family of patents. The listed inventors of the new patent, entitled "VLAN frame format," are Paul J. Frantz and Geoffrey O. Thompson. The patent relates to the field of data communications. More specifically, the patent relates to a method and frame format for preserving in a data frame the virtual local area network, or VLAN, associated with the data frame as determined by a network device from which the data frame was received when transmitting the data frame over a communications medium shared among multiple VLANs.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use